Form 4: Lilly Endowment Inc. Sells Shares in Eli Lilly & Co.

Lilly Endowment Inc. sold a total of 187,106 shares of Eli Lilly & Co. common stock on June 25, 2024, at various weighted average prices.

Summary

• Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., sold a total of 187,106 shares of common stock on June 25, 2024.
• The sales were executed in multiple transactions at weighted average prices ranging from $902.272 to $909.059 per share.
• The transactions resulted in a decrease in Lilly Endowment Inc.'s holdings of Eli Lilly & Co. common stock, from 97,566,913 to 97,368,810 shares.
• The sales were conducted under a pre-arranged 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a share sale by a major shareholder. It does not indicate any positive or negative sentiment about the company's performance or future prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, which is common for large shareholders like Lilly Endowment Inc. It provides transparency into the trading activities of significant stakeholders.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders in publicly traded companies, as mandated by the SEC.
• The transactions are consistent with the requirements of Rule 10b5-1, which allows insiders to sell shares under a pre-arranged plan to avoid accusations of trading on non-public information.
• The volume of shares sold is relatively small compared to the total outstanding shares of Eli Lilly & Co., suggesting it is unlikely to have a significant impact on the overall market.

Stakeholder Impact

• The share sale by Lilly Endowment Inc. may have a minor impact on the stock price of Eli Lilly & Co., but it is unlikely to be significant given the relatively small volume of shares sold compared to the total outstanding shares.
• The transactions are part of a pre-arranged trading plan, which is a common practice for large shareholders.

Key Dates

Keywords

Lilly Endowment Inc., Eli Lilly & Co., share sale, insider trading, Form 4, stock transaction, 10b5-1 plan